Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bacteriophage Infection Mediated by Molecules from Susceptible Organisms

By LabMedica International staff writers
Posted on 26 Jan 2017
A team of Israeli molecular microbiologists has found that bacteria that are resistant to infection by bacteriophages can lose this resistance when incubated together with susceptible bacteria.

The mechanism by which bacteria that are resistant to infection by phages become susceptible had not been well studied. More...
To elucidate this mechanism, investigators at The Hebrew University of Jerusalem investigated phage dynamics in communities harboring phage-resistant (R) and sensitive (S) Bacillus subtilis bacteria.

Using cultures of B. subtilis and its lytic phage SPP1, they demonstrated that R cells, lacking SPP1 receptor, could be lysed by SPP1 when co-cultured with S cells. This unanticipated lysis was triggered in part by phage lytic enzymes released from nearby infected cells. They also discovered that occasionally phages could invade R cells, a phenomenon they termed acquisition of sensitivity (ASEN).

The investigators reported in the January 12, 2017, issue of the journal Cell that ASEN was mediated by R cells transiently gaining phage attachment molecules from neighboring S cells and that this molecular exchange was driven by membrane vesicles. They speculated that this exchange of phage attachment molecules could even occur in an interspecies fashion, enabling phage adsorption to non-host species, providing an unexplored route for horizontal gene transfer (HGT).

"In the present study, we show for the first time how bacteria entirely resistant to a given phage become susceptible upon co-incubation with sensitive bacteria. Phage invasion into resistant cells could have a major impact on transfer of antibiotic resistance and virulence genes among bacteria. This aspect should be carefully considered when employing phage therapy, as phage infection of a given species may result in gene transmission into neighboring bacteria resistant to the phage," said senior author Dr. Sigal Ben-Yehuda, professor of microbiology and molecular genetics at The Hebrew University of Jerusalem.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.